Skip to main content
MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD logo

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD — Investor Relations & Filings

ISIN · MYQ0155OO000 BURSA Human health and social work activities
Filings indexed 17 across all filing types
Latest filing 2026-05-24 Interim / Quarterly Rep…
Country MY Malaysia
Listing BURSA

About MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

https://www.mgrc.com.my/

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD (MGRC) is a leading genomics and biopharmaceutical company specializing in precision medicine. With over 20 years in genomic science, MGRC offers end-to-end solutions including genomic testing, personalized supplements, and advanced cell-based therapies such as Exosome, Mesenchymal Stem Cell (MSC), NK Cell, and CAR-T Cell immunotherapies. The company provides clinically actionable results, with genetic panels optimized for Asian populations, supported by medical experts and operating under international quality standards. MGRC serves patients with chronic or genetic conditions, aging adults, doctors, clinics, and research partners.

Recent filings

Filing Released Lang Actions
Quarterly rpt on consolidated results for the financial period ended 31/03/2026
Interim / Quarterly Report Classification · 94% confidence The document is titled “UNAUDITED FIRST QUARTER REPORT FOR THE FINANCIAL PERIOD ENDED 31 March 2026” and contains full interim financial statements (condensed P&L, balance sheet, cash flows, changes in equity) along with explanatory notes prepared in accordance with MFRS 134. This is a comprehensive quarterly report rather than just an announcement or summary, matching the definition of an Interim / Quarterly Report. Q1 2026
2026-05-24 English
Annual Report & CG Report - 2025
Regulatory Filings
2026-04-29 English
General Meetings: Notice of Meeting
Regulatory Filings
2026-04-28 English
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - BIOV GLOBAL BERHAD
Major Shareholding Notification Classification · 87% confidence The document is a formal notification under Section 137 of the Companies Act 2016 regarding the acquisition of ordinary shares by a substantial shareholder (BIOV GLOBAL BERHAD) resulting in a 5.165% direct interest. It details the number of shares acquired, the date of acquisition, and the updated total shareholding percentages. This matches the description of a Major Shareholding Notification (MRQ).
2026-03-11 English
Quarterly rpt on consolidated results for the financial period ended 31/12/2025
Regulatory Filings
2026-02-25 English
MULTIPLE PROPOSALSMALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR THE "COMPANY") (I) PRIVATE PLACEMENT; AND (II) SHARE CAPITAL REDUCTION (COLLECTIVELY, THE "PROPOSALS")
Share Issue/Capital Change Classification · 91% confidence The document is a company announcement regarding completion of a private placement and a share capital reduction, both of which constitute changes to the company's capital structure. This matches the definition for Share Issue/Capital Change (SHA).
2026-02-11 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.